Clinical Evaluation of the HemoCare™ Hemodialysis System for Home Nocturnal Hemodialysis
Phase: NA
Conditions: End-Stage Renal Disease
Sponsor: Deka Research and Development

DEKA R&D CORP. 
DKPL-00057-001 Rev 1.6 
Page 1 of75 
CLINICAL TRIAL PROTOCOL 
CLINICAL EVALUATION OF THE HEMOCARE™ HEMODIAL YSIS SYSTEM FOR 
HOME NOCTURNAL HEMODIAL YSIS 
Protocol Number: DKPL-00057-001 
NCT04087213 
Sponsor: DEKA Research & Development 
Sponsor Partner: CVS Kidney Care 
Version Number: 1.6 
21 January 2022 
This protocol contains information that is proprietary to DEKA R&D Corp and CVS 
Kidney Care. This information is provided to you for the conduct of a clinical trial for 
DEKA R&D Corp and CVS Kidney Care. You may disclose the contents of this protocol 
to your study personnel under your supervision and your Institutional Review Board or 
Research Ethics Board for the same purpose. You may not disclose the contents of this 
protocol to any other parties (unless such disclosure is required by government regulations 
or laws, in which case, DEKA R&D Corp and CVS Kidney Care, will be notified of the 
disclosure at least 5 business days prior to the disclosure) without prior written permission 
of DEKA R&D Corp and CVS Kidney Care. Any supplemental information (e.g. protocol 
amendment) that may be added to this document is also proprietary to DEKA R&D Corp. 
and CVS Kidney Care, and should be handled using the same disclosure procedure.